Completed NA INTERVENTIONAL 2-arm NCT04982874

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

Bioequivalence Study of Furosemide in Indonesian Healthy Volunteers

Sponsor: PT Pharma Metric Labs

Conditions Drug Use

Interventions Furosemide 40 mg Lasix® 40 mg Tablet

Updated 4 times since 2021 Last updated: Jan 17, 2023 Started: Dec 13, 2019 Primary completion: Jan 17, 2020 Completion: Jan 29, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Drug Use and is currently completed. PT Pharma Metric Labs leads this study, which shows 4 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2023 — Jul 2024 [monthly]

Completed NA
Sep 2021 — Dec 2023 [monthly]

Completed NA

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PT Pharma Metric Labs
PT. Kimia Farma (Persero) Tbk

Data source: PT. Kimia Farma (Persero) Tbk

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta Pusat, Indonesia